Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Haaf, H.
Right arrow Articles by Li, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haaf, H.
Right arrow Articles by Li, J. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 Oxford University Press

research-article

Covalent binding of estrogen metabolites to hamster liver microsomal proteins: inhibition by ascorbic acid and catechol-O-methyl transferase

Heidemarie Haaf, Sara Antonia Li and Jonathan J. Li 1

Medical Research Laboratories, V.A. Medical Center, and Department of Urological Surgery, University of Minnesota Medical School Minneapolis, MN 55417, USA

1To whom reprint requests should be sent

We have studied the irreversible binding of [14C] to hamster liver and kidney microsomes of castrated hamsters. The binding of estradiol metabolites to kidney microsomes was {small tilde}25 times lower than seen for liver microsomes, and was not affected by increases in protein or substrate concentration. Our results indicate that this irreversible binding, covalent in nature, is dependent on the metabolism of estrogens to catechols since the absence of NADPH markedly reduces this binding. The irreversible binding was inhibited nearly 70% by addition of catechol-O-methyl transferase (COMT) and S-adenosylinethionine (SAM). Ascorbic acid also inhibited the binding to 85% in a dose-dependent manner. Utilizing a displacement assay to assess the relative covalent binding of different stilbene and steroidal estrogens with homologous radiolabeled hormones, we found that only inden estrol B exhibited greater ability than diethylslilbestrol (DES) to displace [14C] from hepatic microsomal proteins. Except for hydroxyproplophenone and ß-dienestrol, all of the stilbene estrogens studied displaced the radioactive DES bind ing from these liver proteins to a greater extent than estradlol at comparable concentrations. A marked difference was observed in the ability of {alpha}- and ß-dienestrol to displace [14C] DES. Using radioinert steroldal estrogens to displace [14C] we observed that both estriol and deoxoestrone were significantly less effective in displacing radlolabeled estradiol from liver microsomal proteins. Only ethinyl estradiol and 2-hydroxyestradiol displaced >50% of the radio active hormone at 1-fold excess concentrations. Interestingly, 11ß- methoxyethinyl estradiol (Moxestrol) exhibited essentially the same ability to bind liver microsomal proteins as radlol. When estrone and 2,4-dibromoestradiol were used as substrates together, we found the latter compound to be inactive as a substrate for estrogen hydroxylase (ESH) and additionally inhibited the metabolism of estrone to form the catechol metabolite. Data presented herein suggest that the chemically reactive estrogen metabolites responsible for covalent binding of both stilbene and steroidal estrogens are quinoids derived from catechols formed earlier in metabolism. Except for ethinyl estradiol which is a good substrate for liver, but not kidney microsomal ESH, the carcinogenicity data for the hamster kidney with respect to these estrogens is consistent with the covalent binding data presented.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.